Table 3.

Multivariate analysis of the risk factors for moderate to severe graft fibrosis (IF/TA ≥2) at 12 mo and for graft fibrosis progression (ΔIF/TA ≥1) between 3 and 12 mo

Parameter	12-Mo IF/TA ≥2		ΔIF/TA ≥1
	OR (95% CI)	P	OR (95% CI)	P
Donor agea	1.070 (0.990 to 1.140)	0.055	1.000 (0.970 to 1.040)	0.720
3-Mo EPCb	3.030 (1.143 to 8.050)	0.026	3.160 (1.480 to 6.740)	0.003
3-Mo IF/TA	2.740 (0.580 to 12.940)	0.203	0.380 (0.100 to 1.460)	0.161
3-Mo interstitial infiltrate Banff scoreb	1.000 (0.390 to 2.540)	0.990	0.830 (0.410 to 1.700)	0.620
12-Mo interstitial infiltrate Banff scoreb	3.020 (1.250 to 7.300)	0.014	2.050 (1.020 to 4.120)	0.045

^aPer additional year of age.

^bPer additional score.